Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours
- 1 November 1991
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 64 (5) , 926-932
- https://doi.org/10.1038/bjc.1991.428
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Estradiol modulation of plasminogen activator production in organ cultures of human breast carcinomas: Correlation with clinical outcome of anti‐estrogen therapyInternational Journal of Cancer, 1991
- Cathepsin D assay in primary breast cancer and lymph nodes: Relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasivenessEuropean Journal of Cancer and Clinical Oncology, 1990
- Cathepsin D and Prognosis in Breast CancerNew England Journal of Medicine, 1990
- Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancerJournal of Steroid Biochemistry, 1989
- Detection of both type 1 and type 2 plasminogen activator inhibitors in human cellsJournal of Cellular Physiology, 1988
- Immunohistochemical distribution of the 52-kDa protein in mammary tumors: A marker associated with cell proliferation rather than with hormone responsivenessJournal of Steroid Biochemistry, 1987
- Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomasInternational Journal of Cancer, 1984
- Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activatorInternational Journal of Cancer, 1981
- PRODUCTION BY HUMAN TISSUES IN CULTURE OF IMMUNOLOGICALLY DISTINCT, MULTIPLE MOLECULAR WEIGHT FORMS OF PLASMINOGEN ACTIVATORS*Annals of the New York Academy of Sciences, 1981
- Activation of human breast carcinoma collagenase through plasminogen activatorLife Sciences, 1980